Laboratorio Reig Jofre SA (RJFE)

Currency in EUR
2.760
+0.060(+2.22%)
Delayed Data·
Earnings results expected in 14 days
RJFE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.7602.780
52 wk Range
2.3203.400
Key Statistics
Bid/Ask
2.74 / 2.76
Prev. Close
2.7
Open
2.76
Day's Range
2.76-2.78
52 wk Range
2.32-3.4
Volume
4.08K
Average Volume (3m)
27.89K
1-Year Change
-5.5944%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RJFE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements under the Forté Pharma brand. In addition, the company provides CDMO and CMO services; and management and administration services. It sells its products through business partners. The company was founded in 1929 and is headquartered in Barcelona, Spain. Laboratorio Reig Jofre, S.A. operates as a subsidiary of Reig Jofre Investments SL.

Employees
1512
Market
Spain

Compare RJFE to Peers and Sector

Metrics to compare
RJFE
Peers
Sector
Relationship
P/E Ratio
44.4x18.2x−0.5x
PEG Ratio
−0.830.020.00
Price/Book
1.0x1.8x2.6x
Price / LTM Sales
0.7x1.3x3.2x
Upside (Analyst Target)
-19.7%45.2%
Fair Value Upside
Unlock25.6%6.4%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.06%
Dividend Yield
1.46%
Industry Median 2.43%
Annualised payout
0.04
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
27/02/2026
EPS / Forecast
0.04 / --
Revenue / Forecast
89.1M / --
EPS Revisions
Last 90 days

People Also Watch

8.84
IZER
-0.23%
11.780
MVC
0.00%
3.445
EDRE
-2.13%
2.90
ATRY
0.00%
8.62
MARR
+0.23%

FAQ

What Is the Laboratorio Reig Jofre (RJFE) Share Price Today?

The Laboratorio Reig Jofre stock price today is 2.760 EUR.

What Stock Exchange Does Laboratorio Reig Jofre (RJFE) Trade On?

Laboratorio Reig Jofre is listed and trades on the Madrid Stock Exchange.

What Is the Ticker (Stock Symbol) for Laboratorio Reig Jofre?

The stock symbol (also called a 'ticker') for Laboratorio Reig Jofre is "RJFE."

Does Laboratorio Reig Jofre Pay Dividends? What’s The Current RJFE Dividend Yield?

Yes, RJFE Pays Dividends to its Shareholders. The current Laboratorio Reig Jofre dividend yield is 1.46%.

What Is the Current Laboratorio Reig Jofre Market Cap?

As of today, Laboratorio Reig Jofre market cap is 219.810M EUR.

What Is Laboratorio Reig Jofre's (RJFE) Earnings Per Share (TTM)?

The Laboratorio Reig Jofre EPS is currently 0.060 (Trailing Twelve Months).

When Is the Next Laboratorio Reig Jofre Earnings Date?

Laboratorio Reig Jofre's next earnings report will be released on 07/05/2026.

Is RJFE a Buy or Sell From a Technical Analyst Perspective?

Based on today's Laboratorio Reig Jofre moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Laboratorio Reig Jofre Stock Split?

Laboratorio Reig Jofre has split 10 times. (See the RJFE stock split history page for full effective split date and price information.)

How Many Employees Does Laboratorio Reig Jofre Have?

Laboratorio Reig Jofre has 1512 employees.

What is the current trading status of Laboratorio Reig Jofre (RJFE)?

As of 23/04/2026, Laboratorio Reig Jofre (RJFE) is trading at a price of 2.760 EUR, with a previous close of 2.700 EUR. The stock has fluctuated within a day range of 2.760 EUR to 2.780 EUR, while its 52-week range spans from 2.320 EUR to 3.400 EUR.

Industry Spotlight

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.